drugset / Trial / NCT02567552

Clinical Trial Comparing Endometrial Transformation With Subcutaneous Progesterone Versus Intramuscular Progesterone

NCT02567552

Phase 4 Completed 24 enrolled IVI Barcelona
RandomizedParallel-groupSingle-blindTreatment

Summary

Study the endometrial predecidualization by using subcutaneous progesterone 25 mg/day versus intramuscular progesterone 50 mg/day, to determine whether there are differences in the endometrial transformation and endometrial receptivity.

Timeline

Start
2015-05
Primary completion
2015-12
Completion
2016-01

Drugs

EvaluationDrugModalityDoseRoute
Subject Progesterone Other / unclassified 25 mg Subcutaneous
Subject Progesterone Other / unclassified 50 mg Subcutaneous

Indications

No indication recorded.